Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacogenomics study of telmisartan and indapamide in essential hypertension
ChiCTR-OCH-12002769Phase 4Completed
- Sponsor
- Pharmacogenetics Research Institute, Xiangya Hospital, Central South University
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of telmisartan and indapamide in essential hypertension (2 arms), sponsored by Pharmacogenetics Research Institute, Xiangya Hospital, Central South University. Primary endpoints: Blood pressure and Hypertension-related genes. Started Jan 2008; status: completed.
02
Drugs
telmisartanindapamide
03
Conditions
essential hypertension
Beyond the preview
Go deeper on ChiCTR-OCH-12002769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OCH-12002769.